No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Biomedical Research / trends
-
Chromosome Aberrations*
-
Drug Administration Schedule
-
Gene Expression
-
Hematology / trends*
-
Humans
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / enzymology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Oncogene Proteins, Fusion / antagonists & inhibitors
-
Oncogene Proteins, Fusion / genetics*
-
Oncogene Proteins, Fusion / metabolism
-
Protein Kinase Inhibitors / therapeutic use*
-
Quality of Life
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Oncogene Proteins, Fusion
-
Protein Kinase Inhibitors